FCR001

Talaris Slashes Workforce, Shifts Focus in Restructuring
BioSpace
Thu, 02/16/23 - 11:09 am
Talaris Therapeutics
layoffs
restructuring
FCR001
kidney transplant
Talaris raises $100M series A, reports 70% immune tolerance for allogeneic cell therapy
BioCentury
Fri, 04/19/19 - 10:20 am
Talaris
FCR001
kidney transplant